Advanced in Monkeypox

Valerie Pourcher

47-83 Boulevard De L'Hôpital, 
Paris, FR 
Advanced in Monkeypox
47-83 Boulevard De L'Hôpital, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Valerie Pourcher practices in Paris, France. Ms. Pourcher is rated as an Advanced expert by MediFind in the treatment of Monkeypox. Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Gumma, Mastoidectomy, and Heart Transplant.

Her clinical research consists of co-authoring 150 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Monkeypox.

Gender
Female

Locations

47-83 Boulevard De L'Hôpital, Paris, 75013, France
Other Locations
Clamart, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Other
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
View 1 Less Clinical Trial

150 Total Publications

Trichophyton mentagrophytes ITS genotype VII: transmission in the absence of visible lesions?
Trichophyton mentagrophytes ITS genotype VII: transmission in the absence of visible lesions?
Journal: Dermatologie (Heidelberg, Germany)
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pourcher's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 41 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile